Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.
复制标题
DOI:
10.1038/srep35848
复制
发表时间:
2016-10-20
影响因子:
4.6
通讯作者:
Roszik J
中科院分区:
文献类型:
--
作者:
Bailey P;Chang DK;Forget MA;Lucas FA;Alvarez HA;Haymaker C;Chattopadhyay C;Kim SH;Ekmekcioglu S;Grimm EA;Biankin AV;Hwu P;Maitra A;Roszik J
Immunotherapy approaches for pancreatic ductal adenocarcinoma (PDAC) have met with limited success. It has been postulated that a low mutation load may lead to a paucity of T cells within the tumor microenvironment (TME). However, it is also possible that while neoantigens are present, an effective immune response cannot be generated due to an immune suppressive TME. To discern whether targetable neoantigens exist in PDAC, we performed a comprehensive study using genomic profiles of 221 PDAC cases extracted from public databases. Our findings reveal that: (a) nearly all PDAC samples harbor potentially targetable neoantigens; (b) T cells are present but generally show a reduced activation signature; and (c) markers of efficient antigen presentation are associated with a reduced signature of markers characterizing cytotoxic T cells. These findings suggest that despite the presence of tumor specific neoepitopes, T cell activation is actively suppressed in PDAC. Further, we identify iNOS as a potential mediator of immune suppression that might be actionable using pharmacological avenues.
登录
查看更多内容
影响因子:
4.2
作者:
Janakiram NB;Rao CV
通讯作者:
Rao CV
影响因子:
11.4
作者:
Billard, C;Kern, C;Kolb, JP
通讯作者:
Kolb, JP
影响因子:
45.3
作者:
Le, Dung T.;Wang-Gillam, Andrea;Jaffee, Elizabeth M.
通讯作者:
Jaffee, Elizabeth M.
DOI:
10.1073/pnas.1401799111
发表时间:
2014-04-29
影响因子:
11.1
作者:
Heinecke, Julie L.;Ridnour, Lisa A.;Wink, David A.
通讯作者:
Wink, David A.
DOI:
10.1073/pnas.1320318110
发表时间:
2013-12-10
影响因子:
11.1
作者:
Feig, Christine;Jones, James O.;Fearon, Douglas T.
通讯作者:
Fearon, Douglas T.